公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer | Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU ; Lin, Hsiu-Ping; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Epigenomics | 10 | 9 | |
2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 12 | 13 | |
2014 | Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations | Huang H.-N.; Huang W.-C.; CHING-HUNG LIN ; YING-CHENG CHIANG ; Huang H.-Y.; KUAN-TING KUO | Human Pathology | 18 | 20 | |
2012 | Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects | Chang M.-C.; CHIEN-NAN LEE ; YU-LI CHEN ; YING-CHENG CHIANG ; WEI-ZEN SUN ; Hu Y.-H.; CHI-AN CHEN ; WEN-FANG CHENG | Clinical Science | 11 | 11 | |
2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 1 | 1 | |
2019 | Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model | TZU-PIN LU ; KUAN-TING KUO ; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN | Cancers | 17 | 14 | |
2023 | Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome | PO-HAN LIN ; YU-WEN TIEN ; WEN-FANG CHENG ; YING-CHENG CHIANG ; Wu, Chien-Huei; Yang, Karen; CHIUN-SHENG HUANG | Journal of Gynecologic Oncology | 0 | | |
2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 3 | 3 | |
2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
2021 | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors | Shen, Hung; HENG-CHENG HSU ; YI-JOU TAI ; KUAN-TING KUO ; CHIA-YING WU ; YEN-LING LAI ; YING-CHENG CHIANG ; YU-LI CHEN ; WEN-FANG CHENG | Frontiers in oncology | 5 | 5 | |
2018 | Factors predicting parametrial invasion in patients with early-stage cervical carcinomas | HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | PLoS ONE | 14 | 14 | |
2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 8 | | |
2016 | Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup | JEN-CHIEH LEE ; TZU-PIN LU ; Changou C.A.; Liang C.-W.; Huang H.-N.; Lauria A.; Huang H.-Y.; Lin C.-Y.; YING-CHENG CHIANG ; Davidson B.; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 23 | 21 | |
2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 14 | 13 | |
2021 | Hyaluronan-Loaded Liposomal Dexamethasone-Diclofenac Nanoparticles for Local Osteoarthritis Treatment | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; Chen, Kuan-Yin; YING-CHENG CHIANG | International journal of molecular sciences | 29 | 22 | |
2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 32 | 29 | |